The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Neptune Technologies & Bioressources Inc

TSX: NTB
Delayed quote

$2.32

Today's change+0.03 +1.31%
Updated November 27 3:45 PM EST. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

TSX: NTB
Delayed quote

$2.32

Today's change+0.03 +1.31%
Updated November 27 3:45 PM EST. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc crosses above 125-day moving average

Neptune Technologies & Bioressources Inc closed up Thursday by $0.03 or 1.31% to $2.32 and crossing above its 125-day moving average. Over the last five days, shares have gained 7.41%, but are down 24.68% for the last year to date. Shares have underperformed the S&P TSX by 22.79% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.37
Updated November 27 3:45 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-215.57%

Neptune Technologies & Bioressources Inc has a net profit margin of -215.57%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedAug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014Nov 30, 201311/30/2013
Revenue3444
Total other revenue--------
Total revenue3444
Gross profit-4111
Total cost of revenue7334
Total operating expense1712514
Selling / general / administrative78109
Research & development3222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----10
Other operating expenses, total0-2-110
Operating income-14-8-1-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-4-1-10
Income after tax-15-4-1-10
Income tax, total0000
Net income-13-50-9
Total adjustments to net income--------
Net income before extra. items-13-50-9
Minority interest2022
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-50-9
Inc. avail. to common incl. extra. items-13-50-9
Diluted net income-13-50-9
Dilution adjustment0000
Diluted weighted average shares75736161
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.060.00-0.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.17-0.060.03-0.14